Balancing Risk and Benefit in Elderly Trial Participants
Balancing Risk and Benefit in Elderly Trial Participants Optimizing Risk-Benefit Decisions for Elderly Participants in Clinical Research Regulatory Context for Elderly Participant Protection The global population is aging rapidly, and the inclusion of elderly participants in clinical trials has become essential to ensure therapies are effective and safe in this demographic. Regulatory agencies, including the…
Read More “Balancing Risk and Benefit in Elderly Trial Participants” »